Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT04047706 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04047706
- Sponsor
- Northwestern University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2027-02-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.